Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Roco AM"'
Autor:
Rojo M; Laboratory of Chemical Carcinogenesis and Pharmacogenetics, Department of Basic and Clinical Oncology, Faculty of Medicine, University of Chile, Santiago, Chile.; Latin American Network for Implementation and Validation of Clinical Pharmacogenomics Guidelines (RELIVAF-CYTED), Madrid, Spain., Roco AM; Laboratory of Chemical Carcinogenesis and Pharmacogenetics, Department of Basic and Clinical Oncology, Faculty of Medicine, University of Chile, Santiago, Chile.; Faculty of Life Sciences, Biochemistry Department, Andrés Bello University, Santiago, Chile.; Western Metropolitan Health Service, Santiago, Chile., Suarez M; Laboratory of Chemical Carcinogenesis and Pharmacogenetics, Department of Basic and Clinical Oncology, Faculty of Medicine, University of Chile, Santiago, Chile., Lavanderos MA; Laboratory of Chemical Carcinogenesis and Pharmacogenetics, Department of Basic and Clinical Oncology, Faculty of Medicine, University of Chile, Santiago, Chile.; Latin American Network for Implementation and Validation of Clinical Pharmacogenomics Guidelines (RELIVAF-CYTED), Madrid, Spain., Verón G; Laboratory of Chemical Carcinogenesis and Pharmacogenetics, Department of Basic and Clinical Oncology, Faculty of Medicine, University of Chile, Santiago, Chile., Bertoglia MP; Institute of Population Health, University of Chile, Santiago, Chile., Arredondo A; Institute of Public Health, Andrés Bello University, Santiago, Chile., Nieto E; San Juan de Dios Hospital, Santiago, Chile., Rubilar JC; Laboratory of Chemical Carcinogenesis and Pharmacogenetics, Department of Basic and Clinical Oncology, Faculty of Medicine, University of Chile, Santiago, Chile., Tamayo F; Laboratory of Chemical Carcinogenesis and Pharmacogenetics, Department of Basic and Clinical Oncology, Faculty of Medicine, University of Chile, Santiago, Chile., Cruz D; San Juan de Dios Hospital, Santiago, Chile., Muñoz J; San Juan de Dios Hospital, Santiago, Chile., Bravo G; Curacaví Hospital, Curacaví, Chile., Salas P; Dr. Salvador Allende G. Health Center, Santiago, Chile., Mejías F; San José de Melipilla Hospital, Melipilla, Chile., Véliz P; San José de Melipilla Hospital, Melipilla, Chile., Godoy G; San José de Melipilla Hospital, Melipilla, Chile., Varela NM; Laboratory of Chemical Carcinogenesis and Pharmacogenetics, Department of Basic and Clinical Oncology, Faculty of Medicine, University of Chile, Santiago, Chile.; Latin American Network for Implementation and Validation of Clinical Pharmacogenomics Guidelines (RELIVAF-CYTED), Madrid, Spain., Llull G; San Juan de Dios Hospital, Santiago, Chile., Quiñones LA; Laboratory of Chemical Carcinogenesis and Pharmacogenetics, Department of Basic and Clinical Oncology, Faculty of Medicine, University of Chile, Santiago, Chile.; Latin American Network for Implementation and Validation of Clinical Pharmacogenomics Guidelines (RELIVAF-CYTED), Madrid, Spain.
Publikováno v:
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis [Clin Appl Thromb Hemost] 2020 Jan-Dec; Vol. 26, pp. 1076029620909154.
Autor:
Acevedo CA; Laboratory of Chemical Carcinogenesis and Pharmacogenetics, Center of Pharmacological and Toxicological Research (IFT), ICBM, Program of Molecular and Clinical Pharmacology, Faculty of Medicine, University of Chile, Santiago, Chile; Department of Urology, University of Chile Clinical Hospital (HCUCH), Santiago, Chile; National Cancer Corporation (CONAC), Santiago, Chile., Quiñones LA; Laboratory of Chemical Carcinogenesis and Pharmacogenetics, Center of Pharmacological and Toxicological Research (IFT), ICBM, Program of Molecular and Clinical Pharmacology, Faculty of Medicine, University of Chile, Santiago, Chile. Electronic address: lquinone@med.uchile.cl., Catalán J; Laboratory of Chemical Carcinogenesis and Pharmacogenetics, Center of Pharmacological and Toxicological Research (IFT), ICBM, Program of Molecular and Clinical Pharmacology, Faculty of Medicine, University of Chile, Santiago, Chile., Cáceres DD; Laboratory of Chemical Carcinogenesis and Pharmacogenetics, Center of Pharmacological and Toxicological Research (IFT), ICBM, Program of Molecular and Clinical Pharmacology, Faculty of Medicine, University of Chile, Santiago, Chile; Environmental Health Program, School of Public Health, Faculty of Medicine, University of Chile, Santiago, Chile., Fullá JA; National Cancer Corporation (CONAC), Santiago, Chile., Roco AM; Laboratory of Chemical Carcinogenesis and Pharmacogenetics, Center of Pharmacological and Toxicological Research (IFT), ICBM, Program of Molecular and Clinical Pharmacology, Faculty of Medicine, University of Chile, Santiago, Chile; Department of Processes Management and Care, SSMOC, Santiago, Chile.
Publikováno v:
Urologic oncology [Urol Oncol] 2014 Apr; Vol. 32 (3), pp. 280-90. Date of Electronic Publication: 2014 Feb 06.
Autor:
Quinones LA, Lavanderos MA, Cayun JP, Garcia-Martin E, Agundez JA, Caceres DD, Roco AM, Morales JE, Herrera L, Encina G, Isaza CA, Redal MA, Larovere L, Soria NW, Eslava-Schmalbach J, Castaneda-Hernandez G, Lopez-Cortes A, Magno LA, Lopez M, Chiurillo MA, Rodeiro I, Castro de Guerra D, Teran E, Estevez-Carrizo F, Lares-Assef I; Laboratory of Chemical Carcinogenesis and Pharmacogenetics, IFT, Molecular and Clinical Pharmacology Program, ICBM, Faculty of Medicine, University of Chile; P.O. Box 70111. Carlos Schachtebeck 299, Quinta Normal, Santiago, Chile. lquinone@med.uchile.cl.
Publikováno v:
Current drug metabolism [Curr Drug Metab] 2014 Feb; Vol. 15 (2), pp. 202-8.